Replies to post #167653 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

As a secondary point for sure, as in the trial protocol, but as a primary IMO it would definitely be a material event.

And that is why it's important to note that despite it possibly being an event, and therefore, a material event, the company is not required to 8-K this.

[anders2211]

Mmm no its the other way around if the trial would have failed because it did not meet its primary point(s) and or it becomes over apparent the trial failed for whatever reason then that should be 8K-ed. Since we did not receive such information the trial did not fail (unless NWBO bends/breaks the rules).

Only an SEC specialized lawyer could change my mind if he/she tells me otherwise.
I have read many documents out of professional curiosity Im 99,5% convinced this is an obligation for bio techs..